Shanghai INT Medical Instruments Co (HKSE:01501) Cash And Cash Equivalents : HK$463.4 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co Cash And Cash Equivalents?

Shanghai INT Medical Instruments Co's quarterly cash and cash equivalents declined from Dec. 2022 (HK$578.76 Mil) to Jun. 2023 (HK$501.19 Mil) but then stayed the same from Jun. 2023 (HK$501.19 Mil) to Dec. 2023 (HK$463.40 Mil).

Shanghai INT Medical Instruments Co's annual cash and cash equivalents declined from Dec. 2021 (HK$784.33 Mil) to Dec. 2022 (HK$578.76 Mil) and declined from Dec. 2022 (HK$578.76 Mil) to Dec. 2023 (HK$463.40 Mil).

Shanghai INT Medical Instruments Co Cash And Cash Equivalents Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Cash And Cash Equivalents Chart

Shanghai INT Medical Instruments Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

1,153.68

1,031.48

784.33

578.76

463.40

Shanghai INT Medical Instruments Co Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial								784.33	595.22	578.76	501.19	463.40

Shanghai INT Medical Instruments Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Shanghai INT Medical Instruments Co (HKSE:01501) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Shanghai INT Medical Instruments Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Executives

China Orient Asset Management (international) Holding Limited	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Zhao Wei	2202 Interest of your spouse
Ningbo Huaige Gongxin Equity Investment Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Health Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Ningbo Huaige Taiyi Equity Investment Partnership (limited Partnership)	2101 Beneficial owner
Wang Kai	2201 Interest of corporation controlled by you
Zhao Wei	2202 Interest of your spouse
Shanghai Gongye Investment Co., Ltd.	2201 Interest of corporation controlled by you
Zhang Wei	2501 Other
Worldwide Healthcare Trust Plc	2101 Beneficial owner
Orbimed Capital Llc	2102 Investment manager
Zheng Aiping	2501 Other
Zhang Xianmiao	2501 Other
Zhang Wei	2501 Other

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines